Navidea Biopharmaceuticals Inc (NAVB.A)

NAVB.A on American Stock Exchange

1.66USD
17 Apr 2014
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.66
Open
$1.65
Day's High
$1.68
Day's Low
$1.64
Volume
49,691
Avg. Vol
119,536
52-wk High
$3.21
52-wk Low
$1.16

NAVB.A

Chart for NAVB.A

About

Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company’s radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of... (more)

Overall

Beta: 0.90
Market Cap (Mil.): $248.51
Shares Outstanding (Mil.): 149.70
Dividend: --
Yield (%): --

Financials

  NAVB.A Industry Sector
P/E (TTM): -- 25.58 33.33
EPS (TTM): -0.35 -- --
ROI: -245.35 -2.92 18.94
ROE: -- -12.23 19.69
Search Stocks

Competitors

  Price Change
General Electric Company (GE.N) $26.56 +0.44
Bayer AG (BAYGn.DE) €93.59 +0.66
Bayer AG (BAYE.F) -- --
Eli Lilly and Co (LLY.N) $60.43 +0.47

Earnings vs. Estimates

Search Stocks